Panic disorder, interstitial cystitis, and mast cells

Journal of Clinical Psychopharmacology

Volumn 24, Issue 4, 2004, Pages 361-364

  Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CORTICOTROPIN RELEASING FACTOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CELL STIMULATION; CHROMOSOME 13; DISEASE ASSOCIATION; DRUG EFFICACY; EDITORIAL; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; INTERSTITIAL CYSTITIS; MAST CELL; MIGRAINE; NEUROPATHOLOGY; NEUROPSYCHOLOGY; PANIC; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUBLICATION; STRESS;

CYSTITIS, INTERSTITIAL; FEMALE; HUMANS; LINKAGE (GENETICS); MAST CELLS; PANIC DISORDER;

EID: 3242704081     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000132451.50725.ee     Document Type: Editorial

References (69)

1. Perry D. International Conference on Panic Attacks: diversity of theories and treatments. Expert Opin Pharmacother. 2004;5:977-980.
2. Hamilton SP, Fyer AJ, Durner M, et al. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci USA. 2003;100:2550-2555.
3. Hamilton SP, Slager SL, De Leon AB, et al. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology. 2004;29:558-565.
4. Weissman MM, Gross R, Fyer A, et al. Interstitial cystitis and panic disorder: a potential genetic syndrome. Arch Gen Psychiatry. 2004;61:273-279.
5. Sant GR, Hanno PM. Interstitial cystitis: current issues and controversies in diagnosis. Urology. 2001;57:82-88.
6. Erickson DR, Belchis DA, Dabbs DJ. Inflammatory cell types and clinical features of interstitial cystitis. Urology. 1997;158:790-793.
7. Johansson SL, Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. Urology. 1990;143:1118-1124.
8. Tomaszewski JE, Landis JR, Russack V, et al. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology. 2001;57:67-81.
9. Theoharides TC, Pang X, Letourneau R, et al. Interstitial cystitis: a neuroimmunoendocrine disorder. Ann NY Acad Sci. 1998;840:619-634.
10. Theoharides TC, Pang X, Letourneau R, et al. Interstitial cystitis: a neuroimmunoendocrine disorder. Ann NY Acad Sci. 1998;840:619-634.
11. Theoharides TC, Sant GR. Neuroimmune connections and regulation of function in the urinary bladder. In: Bienenstock J, Goetzl E, Blennerhassett M, eds. Autonomic Neuroimmunology. Lausanne, Switzerland: Hardwood Academic Publishers. 2003:345-369.
12. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol. 2004;146:1-12.
13. Rothrock NE, Lutgendorf SK, Kreder KJ, et al. Stress and symptoms in patients with interstitial cystitis: a life stress model. Urology. 2001;57:422-427.
14. Spanos C, Pang X, Ligris K, et al. Stress-induced bladder mast cell activation: implications for interstitial cystitis. J Urol. 1997;157:669-672.
15. Theoharides TC. Mast cells and stress-A psychoneuroimmunological perspective. J Clin Psychopharmacol. 2002;22:103-108.
16. Feoktistov I, Goldstein AE, Biaggioni I. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. Mol Pharmacol. 1999;55:726-734.
17. Martini C, Trincavelli ML, Tuscano D, et al. Serotonin-mediated phosphorylation of extracellular regulated kinases in platelets of patients with panic disorder versus controls. Neurochem Int. 2004;44:627-639.
18. Suzuki-Nishimura T, Sano T, Uchida MK. Effects of benzodiazepines on serotonin release from rat mast cells. Eur J Pharmacol. 1989;167:75-85.
19. Bidri M, Royer B, Averlant G, et al. Inhibition of mouse mast cell proliferation and proinflammatory mediator release by benzodiazepines. Immunopharmacology. 1999;43:75-86.
20. Theoharides TC. Mast cells: the immune gate to the brain. Life Sci. 1990;46:607-617.
21. Marshall JS, Waserman S. Mast cells and the nerves-Potential interactions in the context of chronic disease. Clin Exp Allergy. 1995;25:102-110.
22. Silver R, Silverman A-J, Vitkovic L. Mast cells in the brain: evidence and functional significance. Trends Neurosci. 1996;19:25-31.
23. Kines KC, Powell HC. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J Neuropathol Exp Neurol. 1997;56:627-640.
24. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev. 2000;173:131-140.
25. Wedemeyer J, Tsai M, Galli SJ. Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol. 2000;12:624-631.
26. Marshall PS. Allergy and depression: a neurochemical threshold model of the relation between the illnesses. Psychol Bull. 1994;113:23-43.
27. Nasr S, Altman EG, Meltzer HY. Concordance of atopic and affective disorders. J Affective Disord. 1981;3:291-296.
28. Matussek P, Agerer D, Seibt G. Allergic disorders in depressed patients. Compr Psychiatry. 1983;24:25-34.
29. Graham DT, Wolf S. The relation of eczema to attitude and to vascular reactions of the human skin. J Lab Clin Med. 1953;42:238-254.
30. Olness K, Hall H, Rozniecki JJ, et al. Mast cell activation in children with migraine before and after training in self-regulation. Headache. 1999;39:101-107.
31. Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology. 2001;57:47-55.
32. Rozniecki JJ, Dimitriadou V, Lambracht-Hall M, et al. Morphological and functional demonstration of rat dura mast cell-neuron interactions in vitro and in vivo. Brain Res. 1999;849:1-15.
33. Ibrahim MZ. The mast cells of the mammalian central nervous system. Part I. Morphology, distribution and histochemistry. J Neurol Sci. 1974;21:431-478.
34. Goldschmidt RC, Hough LB, Glick SD, et al. Mast cells in rat thalamus: nuclear localization, sex difference and left-right asymmetry. Brain Res. 1984;323:209-217.
35. Pang X, Letourneau R, Rozniecki JJ, et al. Definitive characterization of rat hypothalamic mast cells. Neuroscience. 1996;73:889-902.
36. Theoharides TC, Douglas WW. Secretion in mast cells induced by calcium entrapped within phospholipid vesicles. Science. 1978;201:1143-1145.
37. Theoharides TC, Bondy PK, Tsakalos ND, et al. Differential release of serotonin and histamine from mast cells. Nature. 1982;297:229-231.
38. Dvorak AM, Macglashan DW Jr, Morgan ES. Vesicular transport of histamine in stimulated human basophils. Blood. 1996;88:4090-4101.
39. Benyon R, Robinson C, Church MK. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol. 1989;97:898-904.
40. Gagari E, Tsai M, Lantz CS, et al. Differential release of mast cell interleukin-6 via c-kit. Blood. 1997;89:2654-2663.
41. Kandere-Grzybowska K, Letourneau R, Boucher W, et al. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol. 2003;171:4830-4836.
42. Letourneau R, Pang X, Sant GR, et al. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol. 1996;77:41-54.
43. Christian EP, Undem BJ, Weinreich D. Endogenous histamine excites neurones in the guinea-pig superior cervical ganglion in vitro. J Physiol. 1989;409:297-312.
44. Dimitriadou V, Buzzi MG, Moskowitz MA, et al. Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mast cells. Neuroscience. 1991;44:97-112.
45. Keller JT, Dimlich RV, Zuccarello M, et al. Influence of the sympathetic nervous system as well as trigeminal sensory fibres on rat dural mast cells. Cephalalgia. 1991;11:215-221.
46. Delepine L, Aubineau P. Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion. Exp Neurol. 1997;147:389-400.
47. Theoharides TC, Spanos CP, Pang X, et al. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology. 1995;136:5745-5750.
48. Wahl M, Unterberg A, Beathmann A, et al. Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J Cereb Blood Flow Metab. 1988;8:621-634.
49. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol. 2000;20:131-147.
50. Pang X, Cotreau-Bibbo MM, Sant GR, et al. Bladder mast cell expression of high affinity estrogen receptors in patients with interstitial cystitis. Br J Urol. 1995;75:154-161.
51. Vliagoftis H, Dimitriadou V, Boucher W, et al. Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int Arch Allergy Immunol. 1992;98:398-409.
52. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351-1362.
53. Theoharides TC, Singh LK, Boucher W, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology. 1998;139:403-413.
54. Singh LK, Boucher W, Pang X, et al. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors. J Pharmacol Exp Ther. 1999;288:1349-1356.
55. Singh LK, Pang X, Alexacos N, et al. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin and substance P: a link to neurogenic skin disorders. Brain Behav Immunol. 1999;13:225-239.
56. Katsarou-Katsari A, Singh LK, Theoharides TC. Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology. 2001;203:157-161.
57. Kempuraj D, Papadopoulou NG, Lytinas M, et al. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology. 2004;145:43-48.
58. Cao J, Papadopoulou N, Theoharides TC. Identification of functional corticotropin-releasing hormone (CRH) receptor isoforms in human leukemic mast cells (HMC-1). Mol Biol Cell. 2003;14:L212.
59. Papadopoulou N, Cao J, Kempuraj D, Kandere-Grzybowska K, Green M, Boucher W, Theoharides TC. Human umbilical cord derived cultured mast cells (hCBMC) express corticotropin-releasing hormone (CRH) receptors and upregulate CRH-R2 in response to interleukin 4 (IL-4) and lipopolysaccharide (LPS). Endocrinology. In press.
60. Wang J, Dunn AJ. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem Int. 1998;33:143-154.
61. Doyle A, Pollack MH. Long-term management of panic disorder. J Clin Psychiatry. 2004;65:24-28.
62. Theoharides TC, Kops SK, Bondy PK, et al. Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem Pharmacol. 1985;34:1389-1398.
63. 3H] diazepam binding to rat peritoneal mast cells. Life Sci. 1980;27:171-178.
64. Miller LG, Lee-Parritz A, Greenblatt DJ, et al. High affinity benzodiazepine receptors on rat peritoneal mast cells and RBL-1 cells: binding characteristics and effects on granule secretion. Pharmacology. 1988;36:52-60.
65. Dimitriadou V, Pang X, Theoharides TC. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. Int J Immunopharmacol. 2000;22:673-684.
66. Minogiannis P, El-Mansoury M, Betances JA, et al. Hydroxyzine inhibits neurogenic bladder mast cell activation. Int J Immunopharmacol. 1998;20:553-563.
67. Theoharides TC, Sant GR. Hydroxyzine therapy for interstitial cystitis. Urology. 1997;49:108-110.
68. Theoharides TC, Sant GR. New drugs for the treatment of interstitial cystitis. Expert Opin Invest Drugs. 2001;10:527-552.
69. Theoharides TC. The mast cell: a neuroimmunoendocrine master player. Int J Tissue React. 1996;18:1-21.